Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Milestone Pharmaceuticals Inc (NASDAQ: MIST) closed at $1.69 in the last session, down -0.59% from day before closing price of $1.7. In other words, the price has decreased by -$0.59 from its previous closing price. On the day, 1.53 million shares were traded. MIST stock price reached its highest trading level at $1.7299 during the session, while it also had its lowest trading level at $1.66.
Ratios:
We take a closer look at MIST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.97 and its Current Ratio is at 4.97.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $9. Jefferies Downgraded its Buy to Hold on June 20, 2023, whereas the target price for the stock was revised from $8 to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIST now has a Market Capitalization of 143640384 and an Enterprise Value of 125201200.
Stock Price History:
The Beta on a monthly basis for MIST is 0.60, which has changed by 0.14965987 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, MIST has reached a high of $2.75, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -0.89%, while the 200-Day Moving Average is calculated to be -0.75%.
Shares Statistics:
According to the various share statistics, MIST traded on average about 1.42M shares per day over the past 3-months and 1211370 shares per day over the past 10 days. A total of 84.99M shares are outstanding, with a floating share count of 83.51M. Insiders hold about 1.74% of the company’s shares, while institutions hold 20.26% stake in the company. Shares short for MIST as of 1753920000 were 5654252 with a Short Ratio of 3.97, compared to 1751241600 on 1967445. Therefore, it implies a Short% of Shares Outstanding of 5654252 and a Short% of Float of 6.65.
Earnings Estimates
The dynamic stock of Milestone Pharmaceuticals Inc (MIST) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.18 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$0.81 and -$1.03 for the fiscal current year, implying an average EPS of -$0.89. EPS for the following year is -$1.03, with 3.0 analysts recommending between -$0.66 and -$1.53.
